Table 3. RIF Pretreatment X RIF Pos Treatment : Cytometric Parametres
Cytometric Parametres RIF Pretreatment RIF Postreatment P
LBR+
Endometrial thickness (mm) 8.8±2(6-13) 9.64±2.18(6-13) NS
Anormal pathology 8/16 (50) 1/16 (6.2) 0.0031
CFE      
Li/PC 18.18±8.3(6-32) 6.91±4.67(2-16) 0.0045
LT/Li 48.64±20.4(16-71) 52.55±14(38-69) NS
LB/Li 1.64±1.5(0-5) 1.45±2.16(0-5) NS
NK/Li 46.73±21.87(22-82) 36.55±13.9(15-57) 0.078
CD3+CD4/LTCD3+ 49.40±9.83(33-64) 47±7.9(38-65) NS
CD3+CD8/LTCD3+ 50.64±9.3(36-67) 52.18±7.75(35-62) NS
CD4/CD8 1.04±0.39(0.49-1.77) 0.94±0.35(0.6-1.8) NS
NK CD56dimCD16bright 17.56±12.7(5-39) 19.5±11.9(7-44) NS
NKCD56brightCD16dim 80.22±14.66(53-95) 78.5±12.69(55-93) NS
LBR-
Endometrial thickness (mm) 8.4±2.3(6-12) 9.3±1.7(8-13) NS
Anormal pathology 8/14 (57.1) 4/14 (28.57) NS
CFE      
Li/PC 15.57±6.52(4-26) 6.85±3.89(3-15) 0.03
LT/Li 47.85±11.29(36-65) 41.57±14.79(22-69) NS
LB/Li 5.42±4.79(0-11) 2.57±1.39(1-4) NS
NK/Li 40.42±15.70(20-62) 55±13.8(30-75) 0.045
CD3+CD4/LTCD3+ 42.71±15.27(20-65) 44±8.48(35-55) NS
CD3+CD8/LTCD3+ 55.28±14.12(35-80) 54±6.45(45-63) NS
CD4/CD8 0.88±0.53(0.25-1.85) 0.88±0.26(0.59-1.22) NS
NK CD56dimCD16bright 12.42±16.0(3-48) 11.71±4.34(7-20) NS
NKCD56brightCD16dim 85.28±19.98(41-97) 86.42±7.04(72-93) NS